Earth Science Tech, Inc. (OTC: ETST) announced the voting results from its first Annual Meeting of Stockholders, held virtually on Aug. 31, 2026. The meeting marked a pivotal step in the company's strategic evolution, as shareholders approved several proposals aimed at streamlining its capital structure and positioning the company for potential uplisting to a national securities exchange.
Among the key approvals, shareholders green-lighted the board's pursuit of a reverse stock split, which will remain valid for 12 months and will be implemented only if the board determines it necessary to meet minimum bid-price requirements for an uplisting. This move is part of a broader strategy to enhance the company's marketability and access to institutional investors. The approval grants the board flexibility to act decisively when market conditions align with the company's listing objectives.
In a significant governance shift, shareholders authorized the board's independent Special Committee to negotiate the retirement of the Series B Preferred Stock. This action is designed to eliminate the company's dual-class, super-voting control structure, which has been a point of contention for some investors. By retiring these shares, Earth Science Tech aims to simplify its equity structure and align with best practices in corporate governance, potentially making the company more attractive to a wider range of investors.
The meeting also saw approval of the company's cash-only "Say-on-Pay" executive compensation structure, with shareholders electing a three-year review cycle. This decision underscores the board's commitment to transparency and accountability in executive remuneration. Additionally, all seven director nominees were re-elected, and Semple, Marchal & Cooper, LLP was ratified as the independent registered public accounting firm for the upcoming fiscal year.
Earth Science Tech operates as a diversified holding company focused on the health and wellness sector. Its principal strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company's healthcare operations are supported by investments in real estate, asset management activities, and a consumer products business. The core of its value proposition lies in the seamless integration of patient care, from consultation to fulfillment, achieved through the synergy of specialized subsidiaries.
The approval of these proposals is seen as a critical step in Earth Science Tech's journey to enhance shareholder value and potentially achieve a listing on a major exchange. A successful uplisting could provide the company with increased liquidity, broader analyst coverage, and greater visibility among institutional investors. The retirement of the super-voting shares is expected to improve the company's governance profile, which may appeal to ESG-focused investors and proxy advisory firms.
For more details on the meeting and the company's outlook, an audio replay is available, which includes management guidance and a shareholder Q&A session. Earth Science Tech continues to focus on executing its strategic initiatives, with the support of its shareholders, to drive long-term growth in the health and wellness sector.
Investors and stakeholders can access the full press release and additional information about the company through its newsroom at https://ibn.fm/ETST.
